68 related articles for article (PubMed ID: 15795749)
1. Obesity-related correlation between C-reactive protein and the calculated 10-y Framingham Coronary Heart Disease Risk Score.
Rogowski O; Shapira I; Toker S; Melamed S; Shirom A; Berliner S; Zeltser D
Int J Obes (Lond); 2005 Jul; 29(7):772-7. PubMed ID: 15795749
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score.
Albert MA; Glynn RJ; Ridker PM
Circulation; 2003 Jul; 108(2):161-5. PubMed ID: 12835213
[TBL] [Abstract][Full Text] [Related]
3. Body mass index, but not physical activity, is associated with C-reactive protein.
Rawson ES; Freedson PS; Osganian SK; Matthews CE; Reed G; Ockene IS
Med Sci Sports Exerc; 2003 Jul; 35(7):1160-6. PubMed ID: 12840637
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population.
García-Lorda P; Bulló M; Balanzà R; Salas-Salvadó J
Int J Obes (Lond); 2006 Mar; 30(3):468-74. PubMed ID: 16314875
[TBL] [Abstract][Full Text] [Related]
5. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
[TBL] [Abstract][Full Text] [Related]
6. Alanine aminotransferase and high sensitivity C-reactive protein: correlates of cardiovascular risk factors in youth.
Oliveira AC; Oliveira AM; Almeida MS; Silva AM; Adan L; Ladeia AM
J Pediatr; 2008 Mar; 152(3):337-42. PubMed ID: 18280837
[TBL] [Abstract][Full Text] [Related]
7. The associations between current recommendation for physical activity and cardiovascular risks associated with obesity.
Akbartabartoori M; Lean ME; Hankey CR
Eur J Clin Nutr; 2008 Jan; 62(1):1-9. PubMed ID: 17342166
[TBL] [Abstract][Full Text] [Related]
8. High-sensitivity C-reactive protein concentration in a healthy Brazilian population.
Araújo F; Pereira AC; Latorre Mdo R; Krieger JE; Mansur AJ
Int J Cardiol; 2004 Dec; 97(3):433-8. PubMed ID: 15561330
[TBL] [Abstract][Full Text] [Related]
9. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi.
Sharma SK; Mishra HK; Sharma H; Goel A; Sreenivas V; Gulati V; Tahir M
Sleep Med; 2008 Jan; 9(2):149-56. PubMed ID: 17638590
[TBL] [Abstract][Full Text] [Related]
10. Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan.
Wu DM; Chu NF; Shen MH; Wang SC
Clin Biochem; 2006 Aug; 39(8):810-5. PubMed ID: 16814764
[TBL] [Abstract][Full Text] [Related]
11. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy.
Ess SM; Szucs TD
Ital Heart J; 2001 Mar; 2(3):181-8. PubMed ID: 11305529
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk factors in obese women and their first-degree relatives.
Saraç F; Ozgen AG; Yilmaz C; Tüzün M
Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
[TBL] [Abstract][Full Text] [Related]
13. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
[TBL] [Abstract][Full Text] [Related]
15. The association of fruits, vegetables, antioxidant vitamins and fibre intake with high-sensitivity C-reactive protein: sex and body mass index interactions.
Oliveira A; Rodríguez-Artalejo F; Lopes C
Eur J Clin Nutr; 2009 Nov; 63(11):1345-52. PubMed ID: 19623199
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and C-reactive protein among cardiology patients.
Chapidze G; Dolidze N; Enquobahrie DA; Kapanadze S; Latsabidze N; Williams MA
Arch Med Res; 2007 Oct; 38(7):783-8. PubMed ID: 17845899
[TBL] [Abstract][Full Text] [Related]
19. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
[TBL] [Abstract][Full Text] [Related]
20. Differential association of C-reactive protein with adiposity in men and women in an Aboriginal community in northeast Arnhem Land of Australia.
Shemesh T; Rowley KG; Jenkins A; Brimblecombe J; Best JD; O'Dea K
Int J Obes (Lond); 2007 Jan; 31(1):103-8. PubMed ID: 16682979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
